| LENZ Therapeutics, Inc.announced 24 Mar 2026 |
Deploy the expanded sales force |
Being checked30 Jun 2026 |
| LENZ Therapeutics, Inc.announced 24 Mar 2026 |
Expand network television advertising in select markets |
Met30 Jun 2026 |
| LENZ Therapeutics, Inc.announced 7 Jan 2026 |
Launch the VIZZ direct-to-consumer campaign |
Met31 Mar 2026 |
| LENZ Therapeutics, Inc.announced 5 Nov 2025 |
Launch the direct-to-consumer campaign featuring Sarah Jessica Parker |
Met31 Mar 2026 |
| LENZ Therapeutics, Inc.announced 30 Sep 2025 |
Initiate commercial product shipments to consumers |
Met31 Oct 2025 |
| LENZ Therapeutics, Inc.announced 31 Jul 2025 |
Make VIZZ samples and product available in the United States |
Met31 Oct 2025 |
| LENZ Therapeutics, Inc.announced 31 Jul 2025 |
Make commercial product broadly available in the United States |
Met31 Dec 2025 |
| LENZ Therapeutics, Inc.announced 7 May 2025 |
Complete hiring of 88 sales representatives |
Met1 Jul 2025 |
| LENZ Therapeutics, Inc.announced 19 Mar 2025 |
Make LNZ100 available for commercial launch |
Met31 Dec 2025 |
| LENZ Therapeutics, Inc.announced 6 Nov 2024 |
Launch LNZ100 commercially in the United States |
Met31 Dec 2025 |
| LENZ Therapeutics, Inc.announced 8 May 2024 |
Submit New Drug Application for LNZ100 to the FDA |
Late30 Jun 2024 |
| LENZ Therapeutics, Inc.announced 8 May 2024 |
Launch LNZ100 commercially |
Met31 Dec 2025 |
| LENZ Therapeutics, Inc.announced 3 Apr 2024 |
Begin commercialization of LNZ100 |
Met31 Dec 2025 |
| LENZ Therapeutics, Inc.announced 15 Nov 2023 |
Close the merger with Graphite Bio |
Met31 Mar 2024 |
| LENZ Therapeutics, Inc.announced 15 Nov 2023 |
Submit a New Drug Application for at least one product candidate |
Late30 Jun 2024 |
| LENZ Therapeutics, Inc.announced 15 Nov 2023 |
Announce Phase 3 topline data for LNZ100/1 |
Met30 Jun 2024 |
| LENZ Therapeutics, Inc.announced 15 Nov 2023 |
Report Phase 3 topline results from the CLARITY trials |
Met30 Jun 2024 |